• Women's Health
• Breast Health

A Complete Guide To HER2-Positive Breast Cancer

In this article, we’ll explore the symptoms, diagnostic methods, and the latest treatment options for HER2-positive breast cancer.

HER2-positive breast cancer is a type of breast cancer characterized by the overexpression of the HER2 gene, which leads to aggressive cell growth. Understanding this condition is critical, as it influences both the prognosis and treatment decisions.

What is HER2-Positive Breast Cancer?

HER2-positive breast cancer occurs when breast cancer cells have higher-than-normal levels of human epidermal growth factor receptor 2 (HER2). This protein promotes the growth of cancer cells, making HER2-positive breast cancers more aggressive and likely to spread than HER2-negative cancers.

Why is HER2 Status Important?

HER2 status is a critical factor in determining how breast cancer is treated. Women with HER2-positive breast cancer may benefit from targeted therapies that specifically inhibit the HER2 protein, improving survival rates and reducing recurrence risks. Understanding the status helps doctors create personalized treatment plans.

Symptoms of HER2-Positive Breast Cancer

While the symptoms of HER2-positive breast cancer are similar to other forms of breast cancer, the progression may be faster. Common symptoms include:

• A lump in the breast or underarm
• Swelling of part or all of the breast
• Skin irritation or dimpling
• Breast or nipple pain
• Redness or thickening of the nipple or breast skin
• Nipple discharge

Due to the aggressive nature of HER2-positive cancer, it’s essential to seek medical attention promptly if these symptoms appear.

How is HER2-Positive Breast Cancer Diagnosed?

Diagnosis typically begins with a physical examination, mammogram, or ultrasound, followed by a biopsy. During the biopsy, a sample of breast tissue is collected and analyzed for the presence of HER2 protein or gene amplification.

Tests to Confirm HER2 Status

Immunohistochemistry (IHC)

This test measures the amount of HER2 protein on the surface of cells in a sample of breast cancer tissue. The results range from 0 to 3+, with 3+ being considered HER2-positive.

Fluorescence In Situ Hybridization (FISH)

FISH is a more precise test that looks for the number of copies of the HER2 gene in the cancer cells. A positive FISH test confirms HER2 amplification, making the cancer HER2-positive.

Stages of HER2-Positive Breast Cancer

Like other types of breast cancer, HER2-positive breast cancer is classified into stages, ranging from stage 0 (non-invasive cancer) to stage IV (metastatic cancer). Each stage determines how far the cancer has spread and helps guide treatment choices.

• Stage 0: Cancer cells are confined within the milk ducts and haven’t spread.
• Stage I and II: The cancer has spread beyond the ducts but remains localized in the breast or nearby lymph nodes.
• Stage III: Cancer has spread extensively in the breast and nearby areas but not to distant organs.
• Stage IV: Cancer has metastasized to other parts of the body, such as the bones, liver, or lungs.

Treatment Options for HER2-Positive Breast Cancer

Treating HER2-positive breast cancer typically involves a combination of therapies aimed at targeting the aggressive HER2 protein, removing or reducing the tumor, and preventing recurrence.

Targeted Therapies for HER2-Positive Cancer

Trastuzumab (Herceptin)

Trastuzumab is a monoclonal antibody that specifically targets the HER2 protein on cancer cells, blocking its growth-promoting signals. Herceptin is often used in combination with chemotherapy.

Pertuzumab (Perjeta)

This medication works similarly to Herceptin but binds to a different part of the HER2 receptor, providing an additional blockade against cancer growth.

Ado-trastuzumab emtansine (Kadcyla)

This drug combines Herceptin with chemotherapy in one compound, delivering chemotherapy directly to HER2-positive cancer cells, thereby minimizing damage to healthy tissue.

Chemotherapy and Radiation Therapy

In addition to targeted therapies, chemotherapy and radiation therapy are frequently used to treat HER2-positive breast cancer:

• Chemotherapy: Given before or after surgery, chemotherapy helps reduce tumor size and kill any remaining cancer cells.
• Radiation therapy: After surgery, radiation therapy is used to eliminate any leftover cancer cells in the breast or surrounding areas, reducing the risk of recurrence.

Surgical Options

Surgical interventions for HER2-positive breast cancer typically include:

• Lumpectomy: Removal of the tumor and a small margin of surrounding healthy tissue.
• Mastectomy: Removal of one or both breasts, especially in cases of larger or more aggressive tumors.
• Sentinel lymph node biopsy: During surgery, doctors may also remove a few lymph nodes to check if the cancer has spread.

Hormonal Therapies

Although HER2-positive breast cancer is not usually driven by hormones, hormonal therapy may be used if the cancer is also estrogen receptor-positive (ER-positive). In such cases, drugs like tamoxifen or aromatase inhibitors can help reduce the risk of recurrence by blocking the effects of estrogen on cancer cells.

Prognosis for HER2-Positive Breast Cancer

Thanks to advances in targeted therapies, the prognosis for women with HER2-positive breast cancer has improved significantly in recent years. With early detection and appropriate treatment, many women live long, healthy lives following their diagnosis.

Living with HER2-Positive Breast Cancer

Managing the emotional and physical toll of HER2-positive breast cancer can be challenging, but support from healthcare providers, family, and breast cancer support groups can make a significant difference. Regular follow-up care, including mammograms and imaging tests, will help monitor for any signs of recurrence.

Conclusion

HER2-positive breast cancer is an aggressive but treatable condition. Early diagnosis and the use of targeted therapies have revolutionized treatment options and outcomes for women with this diagnosis. If you notice any concerning symptoms or have risk factors for breast cancer, consulting with a healthcare provider as soon as possible is crucial.

FAQs

What is the main difference between HER2-positive and HER2-negative breast cancer?

HER2-positive breast cancer has high levels of the HER2 protein, leading to faster-growing cancer cells. HER2-negative breast cancer does not overexpress this protein, and treatment approaches differ for each type.

How is HER2-positive breast cancer treated?

HER2-positive breast cancer is typically treated with a combination of targeted therapies, chemotherapy, surgery, and sometimes radiation. Targeted therapies like Herceptin specifically target the HER2 protein, slowing cancer growth.

Can HER2-positive breast cancer be cured?

With advances in treatment, many cases of HER2-positive breast cancer can be treated successfully. Early-stage HER2-positive breast cancer has a high chance of successful treatment, especially when targeted therapies are used.

Is HER2-positive breast cancer more aggressive?

Yes, HER2-positive breast cancer tends to be more aggressive than HER2-negative cancers, as it grows and spreads faster. However, targeted therapies have significantly improved outcomes.

What are the side effects of HER2-targeted therapies?

Common side effects of HER2-targeted therapies like Herceptin include fatigue, heart problems, and infusion reactions. However, most side effects are manageable with proper medical care and monitoring.

Disclaimer: The information provided on this website is for general informational purposes only. It is not intended as a substitute for professional advice, diagnosis, or treatment. You can read more about that here: Disclaimers.